Oncology & Cancer
Merck KGaA suffers setback on cancer drug
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Jul 5, 2012
0
0
News tagged with research and development
Health
Increase in physical activity in men optimizes peak bone mass
(HealthDay) -- For young men, increasing physical activity over a five-year period is associated with improvements in bone mineral content (BMC) and bone mineral density (BMD), according to a study published in the May issue ...
May 21, 2012
0
0
Medical research
An international treaty is needed to improve medical research worldwide
An international treaty is a promising tool for improving the coherence, fairness, efficiency, and sustainability of the global health research and development system according to international experts writing in this week's ...
May 15, 2012
0
0
Other
Global health leaders call for global biomedical R&D fund, mechanism
In advance of this month's World Health Assembly and the G7 summit in June, world leaders should consider the establishment of a global biomedical research and development fund and a mechanism to address the dearth in innovation ...
May 11, 2015
0
6
Medications
Genetic test maker 23andMe launches drug R&D effort
Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.
Mar 12, 2015
0
3
Other
GlaxoSmithKline says Q3 net profits drop 18.5%
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Nov 1, 2012
0
0
Health
New report warns of setbacks in global health progress due to current budget climate
The prospect of deep cuts in the federal budget threatens to reverse the dramatic progress of a bipartisan US commitment to defeat neglected diseases in developing countries, according to a new report released today by the ...
Feb 28, 2012
0
0
Medications
Japanese firm buys US pharmaceutical company
(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.
Oct 5, 2012
0
0
Medications
Novartis, Amgen partner on Alzheimer's, migraine treatment
Swiss drug maker Novartis says it will cooperate with California-based biotech giant Amgen to develop and sell neuroscience treatments for illnesses and ailments like Alzheimer's disease and migraine headaches.
Sep 2, 2015
0
12
Medications
Panel cites need for individualized, patient-centered approach for chronic pain
An independent panel convened by the National Institutes of Health concluded that individualized, patient-centered care is needed to treat and monitor the estimated 100 million Americans living with chronic pain. To achieve ...
Jan 13, 2015
0
4
